Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001942842 | SCV002129948 | uncertain significance | not provided | 2025-01-18 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 819 of the CFH protein (p.Asn819Ser). This variant is present in population databases (rs781393769, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with CFH-related conditions. ClinVar contains an entry for this variant (Variation ID: 1365901). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002490027 | SCV002789110 | uncertain significance | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2021-11-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452024 | SCV004177303 | uncertain significance | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003456250 | SCV004177306 | uncertain significance | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452026 | SCV004177307 | uncertain significance | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452025 | SCV004177308 | uncertain significance | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001942842 | SCV005409926 | uncertain significance | not provided | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004815689 | SCV005068898 | uncertain significance | Retinal dystrophy | 2022-01-01 | no assertion criteria provided | clinical testing |